Ross L. Levine, MD
Leukemia Specialist & Physician-Scientist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Request an Appointment
About Me
- Laurence Joseph Dineen Chair in Leukemia Research with Special Emphasis on Leukemia in Children and Young People
- Senior Vice President, Memorial Hospital, Translational Research
I am a physician-scientist focused on researching and treating blood and bone marrow cancers, including acute myeloid leukemia and the chronic myeloproliferative neoplasms polycythemia vera, essential thrombocytosis, and primary myelofibrosis.
Taking care of people with leukemia during my residency and fellowship inspired my interest in the disease. I saw that while our treatments could be quite effective the first go-round, many leukemia patients relapse. That got me thinking about how we could better understand why leukemia develops and how we could create new, targeted treatments to improve outcomes.
Read more
When I am not running my research lab (more information on that here), I treat people with leukemia on an inpatient basis. I do approximately 30 procedures a year, most of which are bone marrow biopsies.
Most people feel overwhelmed when they are first diagnosed, so our job is to give them the information they need and to show them that a whole team of experts is here to help them through the process. My hope is that patients leave our interactions feeling empowered and hopeful.
Outside of work, I love spending time with my family, playing tennis and squash, and rooting for the New York Mets!
A leukemia specialist is a doctor with special training in diagnosing and treating leukemia.
A physician-scientist is a doctor who also is a researcher.
My Specialties
- Leukemias
- Myeloproliferative Neoplasms
Education
- MD, Johns Hopkins University School of Medicine
Residencies
- Internal Medicine - Massachusetts General Hospital
Awards and Honors
- Outstanding Investigations Award, National Cancer Institute (2023)
- Excellence in Scientific Service Award, Leukemia & Lymphoma Society (2023)
- Pershing Square Sohn Prize for Cancer Research (2014), Laurence Joseph Dineen Chair in Leukemia Research (2013), Leukemia and Lymphoma Society Scholar (2012), Boyer Award for Clinical Research, Memorial Sloan Kettering Cancer Center (2011), Howard Hughes Medical Institute Early Career Award (2007), American Society of Hematology Basic Research Fellow Award (2006), American Society of Clinical Oncology Young Investigator Award (2006), American Society of Hematology 2016 Scientific Program co-chair Medical and Scientific Advisory Board, Leukemia and Lymphoma Society
Fellowships
- Hematology/Medical Oncology - Dana Farber Cancer Institute/Partners Cancer Care
Board Certifications
- Internal Medicine
- Hematology
- Medical Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
New Patients
Current Patients
Contact and Location
Dr. Levine sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Patient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Ross L. Levine discloses the following relationships and financial interests:
-
Ajax Therapeutics, Inc.
Equity; Fiduciary Role / Position; Intellectual Property Rights; Professional Services and Activities (Uncompensated) -
Anovia Biosciences, Inc
Equity -
Auron Therapeutics, Inc.
Equity; Professional Services and Activities (Uncompensated) -
Bakx Therapeutics
Equity -
C4 Therapeutics
Equity; Professional Services and Activities -
Cure Breast Cancer Foundation
Intellectual Property Rights -
ECOG-ACRIN Cancer Research Group
Professional Services and Activities (Uncompensated) -
Epiphanes, Inc.
Equity -
Epizyme
Intellectual Property Rights -
Genome Quebec
Professional Services and Activities -
Goldman Sachs
Professional Services and Activities
-
Isoplexis Corporation
Equity; Professional Services and Activities (Uncompensated) -
Jubilant Therapeutics Inc.
Professional Services and Activities -
Kurome Therapeutics, Inc.
Equity; Professional Services and Activities -
Mission Bio
Equity; Professional Services and Activities -
Prelude Therapeutics
Equity; Professional Services and Activities (Uncompensated) -
Qiagen
Equity; Fiduciary Role / Position; Professional Services and Activities (Uncompensated) -
Scorpion Therapeutics, Inc.
Equity; Professional Services and Activities -
Syndax
Equity -
The Mark Foundation
Fiduciary Role / Position; Professional Services and Activities -
Zentalis Pharmaceuticals
Equity; Professional Services and Activities (Uncompensated)
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.